Researchers from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) have applied AI-driven processes for detecting tertiary ...

Adjuvant treatment with dabrafenib and trametinib may be more effective than observation or adjuvant treatment with a PD-1 inhibitor in patients with stage IIIA melanoma.

Reality star and podcaster Teddi Mellencamp, 43, has been fighting for her life after the spread of a deadly form of skin ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

Teddi Mellencamp’s tumors have “shrunk or disappeared.” The 43-year-old TV star has taken to social media to reveal that she’s currently “on course” to make a recovery amid her ongoing cancer ...

For adult males, mortality rates declined for 12 of the most common cancer types between 2018 and 2022, including prostate, liver and intrahepatic bile duct, esophagus, melanoma ... 4.5% each year ...

The latest report on cancer rates and deaths offered a glimmer of hope in the form of decreases in death rates among men and ...

Teddi Mellencamp shares hopeful update on cancer after revealing her ‘50/50’ odds of survival - Mellencamp received her ...

"Our strong execution in the first quarter drove continued momentum across our Growth Portfolio and meaningful progress in the pipeline," said Christopher Boerner, Ph.D., board ch ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

A study published in The Lancet Oncology highlights that pancreatic cancer has a five-year survival rate of less than 10%, largely due to late diagnosis. The average time from diagnosis to death ...

and the relative five-year survival rate is much lower. Among women with mTNBC, the five-year survival rate is 12%, compared with 28% for those with other types of mBC. Despite progress in ...